38 Current Drug Delivery, 2015, Vol. 12, No. 1
Das et al.
[65]
[66]
Muttil, P., Kaur, J., Kumar, K., Yadav, A.B., Sharma, R., Misra, A.
Inhalable microparticles containing large payload of anti-
tuberculosis drugs. Eur. J. Pharm. Sci., 2007, 32,140-150.
Chan, J.G.Y., Tyne, A.S., Pang, A., Chan, H.K., Young, P.M.,
Britton,W. J., Duke, C.C., Traini, D. A Rifapentine-Containing In-
haled Triple Antibiotic Formulation for Rapid Treatment of Tuber-
cular Infection. Pharm. Res., 2013, 1-15.
Adi, H., Larson, I. Stewart, P.J. Adhesion and redistribution of
salmeterol xinafoate particles in sugar-based mixtures for inhala-
tion. Intl. J. Pharm., 2007, 337, 229-238.
Weers, J., Clark, A., Challoner, P. High dose inhaled powder deliv-
ery: challenges and techniques, in: Dalby, R.N., Byron, P.R., Peart,
J. Suman, J.D., Farr, S.J. (Eds.) Respiratory Drug Delivery IX,
Davis Healthcare International Publishing (River Grove, IL, USA),
Palm Desert, CA, USA, 2004, pp. 281-288.
Qui, Y. Adjei, A.L. Gupta, P.K. Absorption and bioavailability of
inhaled peptides and proteins, in: Adjei, A.L., Gupta, P.K. (Eds.)
Inhalation delivery of Therapeutic Peptides and Proteins, Mercel
Dekker, Inc., New York., 1997.
Das, S., Behara, S., Bulitta, J., Morton, D., Larson, I., Stewart, P.
Powder Strength Distributions for Understanding De-
agglomeration of Lactose Powders. Pharm. Res., 2012, 29, 2926-
2935.
Kendall, K., Stainton, C. Adhesion and aggregation of fine parti-
cles. Powder Technol., 2001, 121, 223-229.
Zhou, Q.T., Qu, L., Larson, I. Stewart, P.J. Morton, D.A.V. Im-
proving aerosolization of drug powders by reducing powder intrin-
sic cohesion via a mechanical dry coating approach. Intl. J. Pharm.,
2010, 394, 50-59.
Das, S.C., Luu, J., Morton, D.A.V., Stewart, P. A novel approach
to develop high dose drug alone inhaler in: Drug Delivery to the
Lungs 23 Conference, Edinburgh International Conference Centre,
UK, 2013.
Das, S.C., Morton, D.A.V., Stewart, P. High Dose Drug Only Res-
piratory Delivery - novel approaches to understand aerosolisation
of powders, in: Inhalation Asia, Hongkong, 2013.
Fourie, P. B., Germishuizen, W. A., Yong, Y. L., Edwards, D. A.
Spray drying TB vaccines for pulmonary administration. Expert
Opin. Biol. Ther., 2008, 8, 857-863.
Palazzo, F. Giovagnoli, S., Schoubben, A., Blasi, P., Rossi, C.,
Ricci, M. Development of a spray-drying method for the formula-
tion of respirable microparticles containing ofloxacin-palladium
complex. Intl. J. Pharm., 2013, 440, 273-282.
Seville, P., Li, H., Learoyd, T. Spray-dried powders for pulmonary
drug delivery. Crit. Rev. Ther. Drug Carrier Systems, 2007, 24,
307-360.
Lawlor, C., O’Sullivan, M.P., Rice, B., Dillon, P., Gallagher, P.J.,
O’Leary, S., Shoyel, S., Kean, J. Cryan, S.A. Therapeutic aerosol
bioengineering of targeted, inhaled microparticle formulations to
treat Mycobacterium tuberculosis (MTb). J. Mater. Sci. Mater.
Med., 2012, 23, 89-98.
Changsan, N., Chan, H.K., Separovic, F., Srichana, T. Physico-
chemical Characterization and Stability of Rifampicin Liposome
Dry Powder Formulations for Inhalation. J. Pharm. Sci., 2009, 98,
628-639.
intracellular Mycobacterium tuberculosis. Intl. J. Pharm., 2007,
345, 154-162.
[86]
Bhardwaj, A., Kumar, L. Narang, R.K., Murphy, R.S.R. Develop-
ment and characterization of ligand-appended liposomes for multi-
ple drug therapy for pulmonary tuberculosis. Artificial cells.
Nanomed. Biotechnol., 2013, 41, 52-59.
[87]
[88]
Smith, I.J., Parry-Billings, M. The inhalers of the future? A review
of dry powder devices on the market today. Pulm. Pharmacol.
Ther., 2003, 16, 79-95.
[67]
[68]
Hirota, K., Hasegawa, T., Nakajima, T., Inagawa, H., Kohchi, C.
Soma, G.-I., Makino, K., Terada, H. Delivery of rifampicin-PLGA
microspheres into alveolar macrophages is promising for treatment
of tuberculosis. J. Control. Release, 2010, 142, 339-346.
Via, L., Deretic, D., Ulmer, R., Hibler, N., Huber, L., Deretic, V.
Arrest of mycobacterial phagosome maturation is caused by a
block in vesicle fusion between stages controlled by rab5 and rab7.
J. Biol. Chem., 1997, 272, 13326-13331.
Ferrari, G., Langen, H., Naito, M., Pieters, J. A coat protein on
phagosomes involved in the intracellular survival of mycobacteria.
Cell, 1999, 97,435-447.
Meenach, S.A., Anderson, K.W., Hilt, J.Z., McGarry, R.C., Man-
sour, H.M. Characterization and aerosol dispersion performance of
advanced spray-dried chemotherapeutic PEGylated phospholipid
particles for dry powder inhalation delivery in lung cancer. Eur. J.
Pharm. Sci., 2013, 49, 699-711.
Meenach, S.A. Vogt, F.G., Anderson, K.W., Hilt, J.Z., McGarry,
R.C., Mansour, H.M. Design, physicochemical characterization,
and optimization of organic solution advanced spray-dried in-
halable dipalmitoylphosphatidylcholine (DPPC) and dipalmitoyl-
phosphatidylethanolamine poly(ethylene glycol) (DPPE-PEG) mi-
croparticles and nanoparticles for targeted respiratory nanomedi-
cine delivery as dry powder inhalation aerosols. Int. J. Nanomed.,
2013, 8, 275-293.
Ganguly, S., Moolchandani, V., Roche, J.A., Shapiro, P.S., So-
maraju, S., Eddington, N.D., Dalby, R.N. Phospholipid-induced in
vivo particle migration to enhance pulmonary deposition. J. Aero-
sol. Med. Pulmonary. Drug Deliv., 2008, 23, 181-187.
Lai, S.K., Wang, Y.-Y., Hanes, J. Mucus-penetrating nanoparticles
for drug and gene delivery to mucosal tissues. Adv. Drug Deliv.
Rev., 2009,61, 158-171.
Hu, C., Feng, H., Zhu, C. Preparation and characterization of ri-
fampicin-PLGA microspheres/sodium alginate in situ gel combina-
tion delivery system. Colloids Surfaces B: Biointerfaces, 2012,
95,162-169.
Kirby, D.J., Rosenkrands, I., Agger, E.M., Andersen, P., Coombes,
A.G.A. Perrie Y. PLGA microspheres for the delivery of a novel
subunit TB vaccine. J. Drug Target, 2008, 16, 282-293.
Kumar, G., Malhotra, S., Shafiq, N., Pandhi, P., Khuller, G.K.,
Sharma, S. In vitro physicochemical characterization and short
term in vivo tolerability study of ethionamide loaded PLGA
nanoparticles: Potentially effective agent for multidrug resistant tu-
berculosis. J. Microencapsulation, 2011, 28, 717-728.
Kumar, G. Shafiq, N. Malhotra, S. Drug-loaded PLGA nanoparti-
cles for oral administration: Fundamental issues and challenges
ahead. Crit. Rev. Ther. Drug Carrier Systems, 2012, 29, 149-182.
Lu, D., Garcia-Contreras, L., Xu, D., Kurtz, S.L., Liu, J., Braun-
stein, M., McMurray, D.N., Hickey, A.J. Poly (lactide-co-
glycolide) microspheres in respirable sizes enhance an in vitro T
cell response to recombinant Mycobacterium tuberculosis antigen
85B. Pharm. Res., 2007, 24, 1834-1843.
[89]
[69]
[70]
[90]
[91]
[71]
[72]
[92]
[73]
[74]
[75]
[76]
[93]
[94]
[95]
[77]
[78]
[96]
[97]
[79]
[98]
[99]
[80]
[81]
Misra, A., Jinturkar, K., Patel, D., Lalani, J., Chougule, M. Recent
advances in liposomal dry powder formulations: Preparation and
evaluation. Expert Opin. Drug Deliv., 2009, 6,71-89.
Sethuraman, V.V., Hickey, A.J. Powder Properties and Their Influ-
ence on Dry Powder Inhaler Delivery of an Antituberculosis Drug.
AAPS Pharm. Sci. Tech., 2002, 3, 1-10.
[100] Ohashi, K., Kabasawa, T., Ozeki, T.,Okada, H. One-step prepara-
tion of rifampicin/poly(lactic-co-glycolic acid) nanoparticle-
containing mannitol microspheres using a four-fluid nozzle spray
drier for inhalation therapy of tuberculosis. J. Controlled Release,
2009, 135,19-24.
[101] Jain, P.V., Gudsoorkar, V.R., Jain, D.P., Salunke, K. Preparation
and in vitro evaluation of spray dried microparticles of antitubercu-
lar drugs for pulmonary delivery. Intl. J. Pharm. Sci. Rev. Res.,
2012, 12, 120-128.
[102] Goldbach, P., Brochart, H., Stamm, A. Spray drying of liposomes
for a pulmonary administration. I. Chemical stability of phosphol-
ipids. Drug Devel. Industrial Pharm., 1993, 19, 2611e2622.
[103] Chougule, M., Padhi, B., Misra, A. Nano-liposomal dry powder
inhaler of tacrolimus: preparation, characterization, and pulmonary
pharmacokinetics. Intl. J. Nanomed., 2007, 675, e688.
[82]
[83]
Muttil, P., Wang, C., Hickey, A.J. Inhaled drug delivery for tuber-
culosis therapy. Pharm. Res., 2009, 26, 2401-2416.
Booysen, L.L.I.J., Kalombo, L., Brooks, E., Hansen, R., Gilliland,
J., Gruppo, V., Lungenhofer, P., Semete-Makokotlela, B., Swai,
H.S., Kotze, A.F., Lenaerts, A., Du Plessis, L.H. In vivo/in vitro
pharmacokinetic and pharmacodynamic study of spray-dried poly-
(dl-lactic-co-glycolic) acid nanoparticles encapsulating rifampicin
and isoniazid. Intl. J. Pharm., 2013, 444, 10-17.
[84]
[85]
Son, Y., McConville, J. Preparation of sustained release rifampicin
microparticles for inhalation. J. Pharm. Pharmacol., 2012, 64,
1291-1302.
Kisich, K.O., Gelperina, S., Higgins, M.P., Wilson, S., Shipulo, E.
Oganesyan, E., Heifets, L. Encapsulation of moxifloxacin within
poly(butyl cyanoacrylate) nanoparticles enhances efficacy against